included the presence of either stroke or death at 30 days and any in-hospital adverse events.
FT11. Plaque Prolapse Prevention in Carotid Artery
Objectives: The present positive-control study analyzed and compared the rate of off-table subclinical neurologic events in two groups of patients who underwent protected carotid artery stenting (CAS) with two different kinds of stents, CGuard and Wallstent, in order to assess the efficacy to prevent postprocedural carotid plaque embolism.
Methods: CAS patients affected by asymptomatic carotid stenosis $70% were randomly allocated to be treated by CGuard or Wallstent. They underwent preoperative, immediately postoperative (1 hour), and 72-hour postoperative brain diffusion-weighted magnetic resonance imaging (DWMRI), preoperative and postoperative Mini-Mental State Examination Test (MMSE) and Montreal Cognitive Assessment (MoCA) test assessments, and evaluation of S100B and neuron-specific enolase neurobiomarkers levels at five time points (basal, 2, 12, 24, and 48 hours postoperatively). The primary outcome measure was rate of DWMRI lesions in the two stent groups. Variation in scores on neuropsychometric tests (NPTs) and variation in levels of neurobiomarkers were also analyzed and compared.
Results: From January 2015 to October 2016, 58 patients were randomized at our academic center. In 29 CGuard patients, one minor stroke and eight clinically silent 72-hour DWMRI lesions were detected (31%), and in 29 Wallstent patients, seven clinically silent 72-hour DWMRI lesions were detected (24.1%; P ¼ .38). According to the side of DWMRI lesions, in eight CGuard patients, four had ipsilateral, and four had contralateral or bilateral lesions. In seven Wallstent patients, four had ipsilateral, and three had contralateral or bilateral lesions. Mean DWMRI lesions diameter was 3.87 6 1.53 mm (95% confidence interval, 3.307-4.436) in the CGuard group and 3.56 6 1.07 mm (95% confidence interval, 2.871-4.253) in the Wallstent group (P ¼ .49). Five or more DWMRI lesions were detected in five CGuard patients and three Wallstent patients (P ¼ .5). S100B values doubled at 48 hours postoperatively in 24 patients; among them, 12 presented new DWMRI lesions. The 48-hour S100B increase was significantly related to 72-hour DWMRI lesions (P ¼ .012). Within-group analysis of NPTs showed a significantly better postoperative MoCA score in Wallstent patients (P ¼ .03). NPT postoperative scores showed a significant association with the presence of more than five DWMRI lesions, irrespective of lesion side (P ¼ .007 for MMSE; P ¼ .03 for MoCA).
Conclusions: Wallstent and CGuard stents showed not significant differences in microembolism rates or microemboli number at 72-hour postoperative DWMRI. The 72-hour DWMRI lesions were significantly associated to an increase in neurobiomarkers levels. Five or more lesions were significantly associated to a decrease in NPT postoperative scores in both Wallstent and CGuard groups. A nonnegligible number of bilateral or contralateral lesions were detected in both stent groups. ClinicalTrials. gov reg number: NCT02665585
